Wilson?s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson?s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson?s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson?s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
This report aims to provide a comprehensive presentation of the global market for Wilson's Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wilson's Disease Treatment. This report contains market size and forecasts of Wilson's Disease Treatment in global, including the following market information:
Global Wilson's Disease Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Wilson's Disease Treatment market was valued at US$ 210 million in 2022 and is projected to reach US$ 308.5 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of Wilson?s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson?s disease. Penicillamine is the most successful drug used for the treatment of Wilson?s disease. Wilson?s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson?s disease is Drugs?Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.
We surveyed the Wilson's Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wilson's Disease Treatment Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Wilson's Disease Treatment Market Segment Percentages, by Type, 2022 (%)
D-Penicillamine
Trientine
Tetrathiomolybdate
Others
Global Wilson's Disease Treatment Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Wilson's Disease Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Wilson's Disease Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Wilson's Disease Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wilson's Disease Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Wilson's Disease Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Valeant Pharmaceuticals International. Inc.
Tsumura & Co
Merck & Co
VHB Life Science Inc.
Teva Pharmaceuticals USA, Inc
Wilson's Therapeutics AB
Noble Pharma Co., Ltd
Kadmon Holding, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Wilson's Disease Treatment, market overview.
Chapter 2: Global Wilson's Disease Treatment market size in revenue.
Chapter 3: Detailed analysis of Wilson's Disease Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Wilson's Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Wilson's Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Wilson's Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Wilson's Disease Treatment Overall Market Size
2.1 Global Wilson's Disease Treatment Market Size: 2022 VS 2030
2.2 Global Wilson's Disease Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Wilson's Disease Treatment Players in Global Market
3.2 Top Global Wilson's Disease Treatment Companies Ranked by Revenue
3.3 Global Wilson's Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Wilson's Disease Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Wilson's Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Wilson's Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Wilson's Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Wilson's Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Wilson's Disease Treatment Market Size Markets, 2022 & 2030
4.1.2 D-Penicillamine
4.1.3 Trientine
4.1.4 Tetrathiomolybdate
4.1.5 Others
4.2 By Type - Global Wilson's Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Wilson's Disease Treatment Revenue, 2018-2023
4.2.2 By Type - Global Wilson's Disease Treatment Revenue, 2024-2030
4.2.3 By Type - Global Wilson's Disease Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Wilson's Disease Treatment Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Wilson's Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Wilson's Disease Treatment Revenue, 2018-2023
5.2.2 By Application - Global Wilson's Disease Treatment Revenue, 2024-2030
5.2.3 By Application - Global Wilson's Disease Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Wilson's Disease Treatment Market Size, 2022 & 2030
6.2 By Region - Global Wilson's Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Wilson's Disease Treatment Revenue, 2018-2023
6.2.2 By Region - Global Wilson's Disease Treatment Revenue, 2024-2030
6.2.3 By Region - Global Wilson's Disease Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Wilson's Disease Treatment Revenue, 2018-2030
6.3.2 US Wilson's Disease Treatment Market Size, 2018-2030
6.3.3 Canada Wilson's Disease Treatment Market Size, 2018-2030
6.3.4 Mexico Wilson's Disease Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Wilson's Disease Treatment Revenue, 2018-2030
6.4.2 Germany Wilson's Disease Treatment Market Size, 2018-2030
6.4.3 France Wilson's Disease Treatment Market Size, 2018-2030
6.4.4 U.K. Wilson's Disease Treatment Market Size, 2018-2030
6.4.5 Italy Wilson's Disease Treatment Market Size, 2018-2030
6.4.6 Russia Wilson's Disease Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Wilson's Disease Treatment Market Size, 2018-2030
6.4.8 Benelux Wilson's Disease Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Wilson's Disease Treatment Revenue, 2018-2030
6.5.2 China Wilson's Disease Treatment Market Size, 2018-2030
6.5.3 Japan Wilson's Disease Treatment Market Size, 2018-2030
6.5.4 South Korea Wilson's Disease Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Wilson's Disease Treatment Market Size, 2018-2030
6.5.6 India Wilson's Disease Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Wilson's Disease Treatment Revenue, 2018-2030
6.6.2 Brazil Wilson's Disease Treatment Market Size, 2018-2030
6.6.3 Argentina Wilson's Disease Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Wilson's Disease Treatment Revenue, 2018-2030
6.7.2 Turkey Wilson's Disease Treatment Market Size, 2018-2030
6.7.3 Israel Wilson's Disease Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Wilson's Disease Treatment Market Size, 2018-2030
6.7.5 UAE Wilson's Disease Treatment Market Size, 2018-2030
7 Wilson's Disease Treatment Companies Profiles
7.1 Valeant Pharmaceuticals International. Inc.
7.1.1 Valeant Pharmaceuticals International. Inc. Company Summary
7.1.2 Valeant Pharmaceuticals International. Inc. Business Overview
7.1.3 Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Major Product Offerings
7.1.4 Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Revenue in Global Market (2018-2023)
7.1.5 Valeant Pharmaceuticals International. Inc. Key News & Latest Developments
7.2 Tsumura & Co
7.2.1 Tsumura & Co Company Summary
7.2.2 Tsumura & Co Business Overview
7.2.3 Tsumura & Co Wilson's Disease Treatment Major Product Offerings
7.2.4 Tsumura & Co Wilson's Disease Treatment Revenue in Global Market (2018-2023)
7.2.5 Tsumura & Co Key News & Latest Developments
7.3 Merck & Co
7.3.1 Merck & Co Company Summary
7.3.2 Merck & Co Business Overview
7.3.3 Merck & Co Wilson's Disease Treatment Major Product Offerings
7.3.4 Merck & Co Wilson's Disease Treatment Revenue in Global Market (2018-2023)
7.3.5 Merck & Co Key News & Latest Developments
7.4 VHB Life Science Inc.
7.4.1 VHB Life Science Inc. Company Summary
7.4.2 VHB Life Science Inc. Business Overview
7.4.3 VHB Life Science Inc. Wilson's Disease Treatment Major Product Offerings
7.4.4 VHB Life Science Inc. Wilson's Disease Treatment Revenue in Global Market (2018-2023)
7.4.5 VHB Life Science Inc. Key News & Latest Developments
7.5 Teva Pharmaceuticals USA, Inc
7.5.1 Teva Pharmaceuticals USA, Inc Company Summary
7.5.2 Teva Pharmaceuticals USA, Inc Business Overview
7.5.3 Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Major Product Offerings
7.5.4 Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Revenue in Global Market (2018-2023)
7.5.5 Teva Pharmaceuticals USA, Inc Key News & Latest Developments
7.6 Wilson's Therapeutics AB
7.6.1 Wilson's Therapeutics AB Company Summary
7.6.2 Wilson's Therapeutics AB Business Overview
7.6.3 Wilson's Therapeutics AB Wilson's Disease Treatment Major Product Offerings
7.6.4 Wilson's Therapeutics AB Wilson's Disease Treatment Revenue in Global Market (2018-2023)
7.6.5 Wilson's Therapeutics AB Key News & Latest Developments
7.7 Noble Pharma Co., Ltd
7.7.1 Noble Pharma Co., Ltd Company Summary
7.7.2 Noble Pharma Co., Ltd Business Overview
7.7.3 Noble Pharma Co., Ltd Wilson's Disease Treatment Major Product Offerings
7.7.4 Noble Pharma Co., Ltd Wilson's Disease Treatment Revenue in Global Market (2018-2023)
7.7.5 Noble Pharma Co., Ltd Key News & Latest Developments
7.8 Kadmon Holding, Inc.
7.8.1 Kadmon Holding, Inc. Company Summary
7.8.2 Kadmon Holding, Inc. Business Overview
7.8.3 Kadmon Holding, Inc. Wilson's Disease Treatment Major Product Offerings
7.8.4 Kadmon Holding, Inc. Wilson's Disease Treatment Revenue in Global Market (2018-2023)
7.8.5 Kadmon Holding, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Wilson's Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Wilson's Disease Treatment Market Drivers in Global Market
Table 3. Wilson's Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Wilson's Disease Treatment in Global Market
Table 5. Top Wilson's Disease Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Wilson's Disease Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Wilson's Disease Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Wilson's Disease Treatment Product Type
Table 9. List of Global Tier 1 Wilson's Disease Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Wilson's Disease Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Wilson's Disease Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Wilson's Disease Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Wilson's Disease Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Wilson's Disease Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Wilson's Disease Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Wilson's Disease Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Wilson's Disease Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Wilson's Disease Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Wilson's Disease Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Wilson's Disease Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Wilson's Disease Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Wilson's Disease Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Wilson's Disease Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Wilson's Disease Treatment Revenue, (US$, Mn), 2024-2030
Table 30. Valeant Pharmaceuticals International. Inc. Company Summary
Table 31. Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Product Offerings
Table 32. Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Valeant Pharmaceuticals International. Inc. Key News & Latest Developments
Table 34. Tsumura & Co Company Summary
Table 35. Tsumura & Co Wilson's Disease Treatment Product Offerings
Table 36. Tsumura & Co Wilson's Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Tsumura & Co Key News & Latest Developments
Table 38. Merck & Co Company Summary
Table 39. Merck & Co Wilson's Disease Treatment Product Offerings
Table 40. Merck & Co Wilson's Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Merck & Co Key News & Latest Developments
Table 42. VHB Life Science Inc. Company Summary
Table 43. VHB Life Science Inc. Wilson's Disease Treatment Product Offerings
Table 44. VHB Life Science Inc. Wilson's Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. VHB Life Science Inc. Key News & Latest Developments
Table 46. Teva Pharmaceuticals USA, Inc Company Summary
Table 47. Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Product Offerings
Table 48. Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Teva Pharmaceuticals USA, Inc Key News & Latest Developments
Table 50. Wilson's Therapeutics AB Company Summary
Table 51. Wilson's Therapeutics AB Wilson's Disease Treatment Product Offerings
Table 52. Wilson's Therapeutics AB Wilson's Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Wilson's Therapeutics AB Key News & Latest Developments
Table 54. Noble Pharma Co., Ltd Company Summary
Table 55. Noble Pharma Co., Ltd Wilson's Disease Treatment Product Offerings
Table 56. Noble Pharma Co., Ltd Wilson's Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Noble Pharma Co., Ltd Key News & Latest Developments
Table 58. Kadmon Holding, Inc. Company Summary
Table 59. Kadmon Holding, Inc. Wilson's Disease Treatment Product Offerings
Table 60. Kadmon Holding, Inc. Wilson's Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Kadmon Holding, Inc. Key News & Latest Developments
List of Figures
Figure 1. Wilson's Disease Treatment Segment by Type in 2022
Figure 2. Wilson's Disease Treatment Segment by Application in 2022
Figure 3. Global Wilson's Disease Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Wilson's Disease Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Wilson's Disease Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Wilson's Disease Treatment Revenue in 2022
Figure 8. By Type - Global Wilson's Disease Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Wilson's Disease Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global Wilson's Disease Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Wilson's Disease Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global Wilson's Disease Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Wilson's Disease Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global Wilson's Disease Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America Wilson's Disease Treatment Revenue Market Share, 2018-2030
Figure 16. US Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Wilson's Disease Treatment Revenue Market Share, 2018-2030
Figure 20. Germany Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Wilson's Disease Treatment Revenue Market Share, 2018-2030
Figure 28. China Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Wilson's Disease Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Wilson's Disease Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Wilson's Disease Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Tsumura & Co Wilson's Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck & Co Wilson's Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. VHB Life Science Inc. Wilson's Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Wilson's Therapeutics AB Wilson's Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Noble Pharma Co., Ltd Wilson's Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kadmon Holding, Inc. Wilson's Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
